Consensus Stryker Corporation

Stocks

SYK

US8636671013

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe BZX 01:42:32 09/10/26 am AEDT			5-day change	1st Jan Change
272.86 ^USD	-0.92%		+0.00%	-22.33%

07/10	Stryker Corporation Announces CEO Changes, Effective January 1, 2027	CI
07/10	Stryker Corporation Announces Management Changes, Effective January 1, 2027	CI

Evolution of the Average Target: Stryker Corporation

Evolution of the Target Price: Stryker Corporation

Changes in Analyst Recommendations: Stryker Corporation

c5fa5fdd941be3144.8ENHxPqFfsw3kKlC0FUpQTUbIjIZQ7oXfKk1e6j1VEQ.wjYF8rTqTLh26fMStQpwdHcrdgZXdtxBCfBqDf66OwWKDgj2vfQQiVD33g~7150e1f25f34cf6b84098a0e204e5fd2

Analysts' recommendations: Stryker Corporation

07/10	Truist Securities Cuts Stryker Price Target to $310 From $340, Maintains Hold Rating	MT
07/10	Evercore ISI Adjusts Price Target on Stryker to $335 From $355, Keeps Outperform Rating	MT
07/10	Evercore ISI Adjusts Stryker Price Target to $335 From $355, Maintains Outperform Rating	MT
30/09	Stifel Adjusts Price Target on Stryker to $330 From $360, Maintains Buy Rating	MT
22/09	TD Cowen Adjusts Price Target on Stryker to $298 From $355, Keeps Hold Rating	MT
22/09	Jefferies Adjusts Price Target on Stryker to $405 From $440, Keeps Buy Rating	MT
21/09	Raymond James Adjusts Price Target on Stryker to $330 From $370, Keeps Outperform Rating	MT
18/09	Canaccord Genuity Adjusts Price Target on Stryker to $385 From $400, Keeps Buy Rating	MT
18/09	Stryker Facing Promising Setup Next Year, Trading Upside Limited in 2026, RBC Says	MT
14/09	Bernstein Adjusts Price Target on Stryker to $385 From $420, Keeps Outperform Rating	MT
09/09	Citigroup Adjusts Stryker Price Target to $360 From $399, Maintains Buy Rating	MT
09/09	Wells Fargo Adjusts Price Target on Stryker to $348 From $418, Keeps Overweight Rating	MT
09/09	BMO Capital Adjusts Price Target on Stryker to $317 From $369, Keeps Outperform Rating	MT
18/08	Leerink Partners Adjusts Price Target on Stryker to $403 From $407, Maintains Outperform Rating	MT
13/08	Citigroup Adjusts Price Target on Stryker to $399 From $385, Maintains Buy Rating	MT
06/08	Rothschild & Co Redburn Adjusts Stryker Price Target to $360 From $346	MT
04/08	UBS Adjusts Stryker Price Target to $382 From $400, Maintains Buy Rating	MT
03/08	Analyst recommendations: Chevron, Linde, RTX, Colgate-Palmolive, American Electric Power...
31/07	RBC Cuts Price Target on Stryker to $420 From $435, Keeps Outperform Rating	MT
31/07	Evercore ISI Adjusts Stryker Price Target to $355 From $350, Maintains Outperform Rating	MT
31/07	Truist Lifts Price Target on Stryker to $340 From $330, Keeps Hold Rating	MT
31/07	Raymond James Adjusts Price Target on Stryker to $370 From $383, Maintains Outperform Rating	MT
31/07	Jefferies Adjusts Price Target on Stryker to $440 From $455, Maintains Buy Rating	MT
31/07	BTIG Adjusts Price Target on Stryker to $358 From $371, Maintains Buy Rating	MT
31/07	Piper Sandler Adjusts Price Target on Stryker to $390 From $420, Maintains Overweight Rating	MT

More recommendations

Medical Devices & Implants

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	STRYKER CORPORATION					+32.95%
	ABBOTT LABORATORIES					+22.27%
	MEDTRONIC PLC					+22.14%
	ESSILORLUXOTTICA					+55%
	CENCORA, INC.					+16.6%
	HOYA CORPORATION					+20.15%
	BECTON, DICKINSON AND COMPANY					+7.72%
	IDEXX LABORATORIES, INC.					+38.42%
	DEXCOM, INC.					+14.15%
	MEDLINE INC.					+25.53%
	Average					+25.49%
	Weighted average by Cap.					+26.26%